Review Article

Mengenal New Psychoactive Substances (NPS): sebuah tinjauan pustaka

Ni Made Leni , Luh Nyoman Alit Aryani, I Wayan Westa

Ni Made Leni
Program Pendidikan Dokter Spesialis Ilmu Kedokteran Jiwa, Fakultas Kedokteran, Universitas Udayana, RSUP Sanglah, Bali, Indonesia. Email: nimadeleni@yahoo.co.id

Luh Nyoman Alit Aryani
Departemen Psikiatri, Fakultas Kedokteran, Universitas Udayana, RSUP Sanglah, Bali, Indonesia

I Wayan Westa
Departemen Psikiatri, Fakultas Kedokteran, Universitas Udayana, RSUP Sanglah, Bali, Indonesia
Online First: April 30, 2021 | Cite this Article
Leni, N., Aryani, L., Westa, I. 2021. Mengenal New Psychoactive Substances (NPS): sebuah tinjauan pustaka. Intisari Sains Medis 12(1): 275-284. DOI:10.15562/ism.v12i1.929


Drug abuse is a global phenomenon that is difficult to control. Until now, various types of narcotics have been distributed in many countries, one of which is New Psychoactive Substances (NPS). Despite its fast growing and massive spread, NPS is still a new substance, considering the little number of data recorded up to recent days. This also results in difficulty of NPS identification in toxicological samples . The use of NPS is associated with many health problems, which causes physical and psychological disturbance potentially more severe than ordinary narcotics. This review aims to summarize the existing literature on NPS that focuses on identifying the types of NPS substances and symptoms as well as the management which could be provided to the patients.

 

Penyalahgunaan narkotika merupakan fenomena global yang sulit dikendalikan, hingga saat ini variasi narkotika telah beredar di begitu banyak negara salah satunya termasuk Zat Psikoaktif Baru atau New Psychoactive Substances (NPS).  Terlepas dari penyebarannya yang cepat dan masif, masih banyak orang yang belum memiliki pengetahuan akan NPS mengingat pendataan zat-zat ini masih sedikit dilakukan. Hal tersebut juga menyebabkan identifikasi NPS dalam sampel toksikologi masih sulit dilakukan. Padahal penggunaan NPS sering dikaitkan dengan masalah kesehatan, dimana efek yang ditimbulkan dapat menyebabkan gejala gangguan fisik dan psikologis yang lebih berat dibandingkan zat narkotika pada umumnya. Tinjauan ini dibuat untuk merangkum literatur yang ada mengenai NPS yang berfokus pada pengenalan jenis-jenis zat NPS serta gejala juga tatalaksana yang dapat diberikan pada pasien pengguna NPS.

References

Badan Narkotika Nasional. Narkoba dalam Angka-Jurnal Data Puslitdatin BNN 2018 Hasil Survei Penyalahgunaan Narkoba pada Pekerja Tahun 2017. Jakarta: Puslidatin Badan Narkotika Nasional. 2017.

Welter-Luedeke J, Maurer HH. New Psychoactive Substances: Chemistry, Pharmacology, Metabolism, and Detectability of Amphetamine Derivatives With Modified Ring Systems. Ther Drug Monit. 2016;38(1):4-11.

Miliano C, Serpelloni G, Rimondo C, Mereu M, Marti M, De Luca MA. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Front Neurosci. 2016;10:153.

Lee J, Yang S, Kang Y, Han E, Feng LY, Li JH, et al. Prevalence of new psychoactive substances in Northeast Asia from 2007 to 2015. Forensic Sci Int. 2017;272:1-9.

Suryawati SWD. UGM Mengajak: Raih Prestasi Tanpa Narkoba. Yogyakarta: Gadjah Mada University Press. 2015.

Undang-Undang Republik Indonesia Nomor 22 Tahun 1997 Tentang Narkotika. Jakarta. 1997.

Undang-Undang Republik Indonesia nomor 5 tahun 1997 tentang psikotropika. Jakarta. 1997.

Badan Narkotika Nasional. Jurnal Data Puslitdatin Tahun 2018: Indonesia Dalam Angka Tahun 2017. Jakarta: Badan Narkotika Nasional. 2018.

Grundmann O. Patterns of Kratom use and health impact in the US-Results from an online survey. Drug Alcohol Depend. 2017;176:63-70.

Soria ML. New psychoactive substances: Popular and dangerous. Spanish Journal of Legal Medicine. 2018;44(2):64-72.

Guirguis A, Girotto S, Berti B, Stair JL. Identification of new psychoactive substances (NPS) using handheld Raman spectroscopy employing both 785 and 1064nm laser sources. Forensic Sci Int. 2017;273:113-123.

Orsolini L, Chiappini S, Corkery JM, Guirguis A, Papanti D, Schifano F. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review. Expert Rev Neurother. 2019;19(12):1253-1264.

Madras BK. The Growing Problem of New Psychoactive Substances (NPS). Curr Top Behav Neurosci. 2017;32:1-18.

Pieprzyca E, Skowronek R, Nižnanský ?, Czekaj P. Synthetic cathinones - From natural plant stimulant to new drug of abuse. Eur J Pharmacol. 2020;875:173012.

De Felice LJ, Glennon RA, Negus SS. Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology. Life Sci. 2014;97(1):20-26.

Badan Narkotika Nasional. Indonesia Drug Report 2019. Jakarta: PUSLITDATIN. 2019.

Luo X, Reiter MA, d'Espaux L, Wong J, Denby CM, Lechner A, et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature. 2019;567(7746):123-126.

Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. A survey of synthetic cannabinoid consumption by current cannabis users. Subst Abus. 2014;35(2):184-189.

Van Buskirk J, Griffiths P, Farrell M, Degenhardt L. Trends in new psychoactive substances from surface and "dark" net monitoring. Lancet Psychiatry. 2017;4(1):16-18.

Khan MZ, Nawaz W. The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system. Biomed Pharmacother. 2016;83:439-449.

Maas A, Wippich C, Madea B, Hess C. Driving under the influence of synthetic phenethylamines: a case series. Int J Legal Med. 2015;129(5):997-1003.

Konsorsium Internasional Kebijakan NAPZA. Panduan Kebijakan Napza, Panduan Kebijakan, psikotropika dan Zat Adiktif lainnya (NAPZA). International Drug Policy Consortium. 2012;2:75-90.

Karila L, Megarbane B, Cottencin O, Lejoyeux M. Synthetic cathinones: a new public health problem. Curr Neuropharmacol. 2015;13(1):12-20.

Safhi MM, Alam MF, Hussain S, Hakeem Siddiqui MA, Khuwaja G, Jubran Khardali IA, et al. Cathinone, an active principle of Catha edulis, accelerates oxidative stress in the limbic area of swiss albino mice. J Ethnopharmacol. 2014;156:102-6.

Feng LY, Battulga A, Han E, Chung H, Li JH. New psychoactive substances of natural origin: A brief review. J Food Drug Anal. 2017;25(3):461-471.

Luliana S, Robiyanto, Islamy MR. Aktivitas Antinosiseptif Fraksi Diklorometana Daun Kratom (Mitragyna speciosa Korth.) Rute Oral Pada Mencit Jantan Swiss. Pharm Sci Res. 2018;5(2):58-64.

Beckett AH, Shellard EJ, Phillipson JD, Lee CM. Alkaloids from Mitragyna speciosa (Korth.). J Pharm Pharmacol. 1965;17(11):753-755.

Kousara K, Anjuma SN, Jaleela F, Khana J, Naseema S. Biomedical Significance of Triptamin: A Review. Journal of Pharmacovigilance. 2017;5(5);1-6.

Wallach J, Brandt SD. Phencyclidine-Based New Psychoactive Substances. Handb Exp Pharmacol. 2018;252:261-303.

Miliano C, Serpelloni G, Rimondo C, Mereu M, Marti M, De Luca MA. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Front Neurosci. 2016;10:153.


No Supplementary Material available for this article.
Article Views      : 376
PDF Downloads : 262